[go: up one dir, main page]

WO2007124132A3 - Compositions polymères et procédés de production et d'utilisation de ces compositions - Google Patents

Compositions polymères et procédés de production et d'utilisation de ces compositions Download PDF

Info

Publication number
WO2007124132A3
WO2007124132A3 PCT/US2007/009797 US2007009797W WO2007124132A3 WO 2007124132 A3 WO2007124132 A3 WO 2007124132A3 US 2007009797 W US2007009797 W US 2007009797W WO 2007124132 A3 WO2007124132 A3 WO 2007124132A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymeric compositions
making
methods
moiety
crosslinking
Prior art date
Application number
PCT/US2007/009797
Other languages
English (en)
Other versions
WO2007124132A2 (fr
Inventor
Kavita Gupta
Meredith C Roberts
Patrick F Kiser
Julie I Jay
Original Assignee
Univ Utah Res Found
Kavita Gupta
Meredith C Roberts
Patrick F Kiser
Julie I Jay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found, Kavita Gupta, Meredith C Roberts, Patrick F Kiser, Julie I Jay filed Critical Univ Utah Res Found
Priority to AU2007240613A priority Critical patent/AU2007240613B2/en
Priority to CA002649915A priority patent/CA2649915A1/fr
Priority to US12/226,547 priority patent/US20100285094A1/en
Priority to EP07755883A priority patent/EP2012803A4/fr
Publication of WO2007124132A2 publication Critical patent/WO2007124132A2/fr
Publication of WO2007124132A3 publication Critical patent/WO2007124132A3/fr
Priority to US13/742,877 priority patent/US8747870B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F232/00—Copolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2190/00—Compositions for sealing or packing joints

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

L'invention concerne des compositions polymères qui contiennent au moins un résidu polymère et au moins une fraction de réticulation. Ledit résidu polmyère est réticulé par la fraction de réticulation, et la fraction de réticulation est formée par réaction entre une fraction acide boronique et une fraction acide hydroxamique. L'ivnention concerne également des procédés de production et d'utilisation de ces composiitons polymères.
PCT/US2007/009797 2006-04-20 2007-04-20 Compositions polymères et procédés de production et d'utilisation de ces compositions WO2007124132A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2007240613A AU2007240613B2 (en) 2006-04-20 2007-04-20 Polymeric compositions and methods of making and using thereof
CA002649915A CA2649915A1 (fr) 2006-04-20 2007-04-20 Compositions polymeres et procedes de production et d'utilisation de ces compositions
US12/226,547 US20100285094A1 (en) 2006-04-20 2007-04-20 Polymeric compositions and methods of making and using thereof
EP07755883A EP2012803A4 (fr) 2006-04-20 2007-04-20 Compositions polymères et procédés de production et d'utilisation de ces compositions
US13/742,877 US8747870B2 (en) 2006-04-20 2013-01-16 Polymeric compositions and methods of making and using thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US79368206P 2006-04-20 2006-04-20
US60/793,682 2006-04-20
US88188907P 2007-01-23 2007-01-23
US60/881,889 2007-01-23

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/226,547 A-371-Of-International US20100285094A1 (en) 2006-04-20 2007-04-20 Polymeric compositions and methods of making and using thereof
US13/742,877 Continuation US8747870B2 (en) 2006-04-20 2013-01-16 Polymeric compositions and methods of making and using thereof

Publications (2)

Publication Number Publication Date
WO2007124132A2 WO2007124132A2 (fr) 2007-11-01
WO2007124132A3 true WO2007124132A3 (fr) 2008-11-13

Family

ID=38625658

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/009797 WO2007124132A2 (fr) 2006-04-20 2007-04-20 Compositions polymères et procédés de production et d'utilisation de ces compositions

Country Status (5)

Country Link
US (1) US20100285094A1 (fr)
EP (1) EP2012803A4 (fr)
AU (1) AU2007240613B2 (fr)
CA (1) CA2649915A1 (fr)
WO (1) WO2007124132A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410190B2 (en) * 2009-09-22 2013-04-02 Coopervision International Holding Company, Lp Wettable hydrogel materials for use in ophthalmic applications and methods

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US8747870B2 (en) 2006-04-20 2014-06-10 University Of Utah Research Foundation Polymeric compositions and methods of making and using thereof
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
BRPI0801422B8 (pt) 2008-03-26 2021-05-25 Fund Sao Francisco Xavier composição e método para inibição da severidade das aderências pós-cirúrgicas
CA2721045A1 (fr) * 2008-04-09 2009-10-15 Mcmaster University Hydrogel a coeur reticule par covalence
US8083347B2 (en) * 2008-04-29 2011-12-27 Ocugenics, LLC Drug delivery system and methods of use
US9216188B2 (en) 2008-09-04 2015-12-22 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
GB2468503A (en) * 2009-03-11 2010-09-15 Univ Sheffield A dressing comprising an electrospun scaffold and a nonsteroidal anti-inflammatory drug
US9296988B2 (en) 2009-06-19 2016-03-29 The Regents Of The University Of California Three-dimensional cell adhesion matrix
US8709489B2 (en) 2009-09-30 2014-04-29 Surmodics, Inc. Emulsions containing arylboronic acids and medical articles made therefrom
US20110208190A1 (en) * 2010-02-23 2011-08-25 University Of Connecticut Natural Polymer-Based Porous Orthopedic Fixation Screw for Bone Repair and Regeneration
WO2011109730A2 (fr) 2010-03-04 2011-09-09 The General Hospital Corporation Procédés et systèmes de compensation des déficiences vocales au moyen d'un implant de muqueuse adaptable permettant de rétablir et renforcer la production sonore et vocale humaine individualisée
EP3675082B1 (fr) 2010-10-01 2022-03-16 Applied Medical Resources Corporation Dispositif d'apprentissage portatif pour laparoscopie.
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2012074994A1 (fr) * 2010-11-29 2012-06-07 The Regents Of The University Of Colorado, A Body Corporate Nouveaux échafaudages à réseau thermoréversible et leurs procédés de préparation
US20140017165A1 (en) * 2011-01-11 2014-01-16 Zhuang Wang Dna repair enzyme inhibitor nanoparticles and uses thereof
JP5998158B2 (ja) * 2011-03-02 2016-09-28 センスリン，エルエルシー ベシクル組成物
JP6169088B2 (ja) 2011-10-21 2017-07-26 アプライド メディカル リソーシーズ コーポレイション 外科訓練のための模擬組織構造
US9283301B1 (en) * 2011-12-14 2016-03-15 Clemson University Shape-memory sponge hydrogel biomaterial
AU2012358851B2 (en) 2011-12-20 2016-08-11 Applied Medical Resources Corporation Advanced surgical simulation
USH2276H1 (en) 2012-01-09 2013-06-04 The United States Of America, As Represented By The Secretary Of The Navy Branched amide polymeric superabsorbents
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
JP6275707B2 (ja) * 2012-06-20 2018-02-07 フランク・グー 粘膜付着性ナノ粒子送達系
CN104812419B (zh) * 2012-06-28 2017-06-09 图兰恩教育基金管理人 选择性可聚合组合物及其活体内使用方法
CA2878404A1 (fr) 2012-07-10 2014-01-16 The Trustees Of The University Of Pennsylvania Biomateriaux destines a ameliorer l'integration de l'implant au sein de l'hote
KR102105979B1 (ko) 2012-09-26 2020-05-04 어플라이드 메디컬 리소시스 코포레이션 복강경 절차들을 위한 수술 훈련 모델
EP3483862B1 (fr) 2012-09-27 2021-03-03 Applied Medical Resources Corporation Modèle de formation chirurgicale pour des procédures laparoscopiques
US10679520B2 (en) 2012-09-27 2020-06-09 Applied Medical Resources Corporation Surgical training model for laparoscopic procedures
US20150320675A1 (en) * 2013-01-18 2015-11-12 University Of Utah Research Foundation Modified Release Osmotic Pump for PH-Responsive Drug Delivery
KR20250004119A (ko) 2013-03-01 2025-01-07 어플라이드 메디컬 리소시스 코포레이션 진보된 수술 시뮬레이션 구성물들 및 방법들
CN105246401B (zh) 2013-03-11 2019-11-22 犹他大学研究基金会 传感器系统
JP6496717B2 (ja) 2013-06-18 2019-04-03 アプライド メディカル リソーシーズ コーポレイション 外科的処置を教示すると共に練習するための胆嚢モデル
HK1224020A1 (zh) 2013-06-20 2017-08-11 Mercy Medical Research Institute 延長釋放藥物傳遞的隱形眼鏡及其製造方法
US10198966B2 (en) 2013-07-24 2019-02-05 Applied Medical Resources Corporation Advanced first entry model for surgical simulation
KR102239454B1 (ko) 2013-07-24 2021-04-13 어플라이드 메디컬 리소시스 코포레이션 제 1 진입 모델
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2015080657A1 (fr) * 2013-11-28 2015-06-04 Ge Healthcare Bio-Sciences Ab Stabilisation de boissons fermentées
FR3016885B1 (fr) * 2014-01-27 2017-08-18 Total Marketing Services Copolymeres thermoassociatifs et echangeables, compositions les comprenant
JP6496252B2 (ja) * 2014-02-05 2019-04-03 国立大学法人 筑波大学 ポリカチオン性トリブロックコポリマーとポリアニオン性ポリマーの組成物を含む癒着防止用製剤
EP3106548B1 (fr) * 2014-02-14 2019-01-02 Nissan Chemical Corporation Composition contenant des groupes esters actifs servant à la production de fibres, et matériel de support de culture cellulaire faisant intervenir des fibres produites à partir de ladite composition contenant des groupes esters actifs
AU2015235994B2 (en) 2014-03-26 2019-11-21 Applied Medical Resources Corporation Simulated dissectible tissue
WO2015170757A1 (fr) * 2014-05-08 2015-11-12 国立大学法人 東京大学 Composition pharmaceutique
KR101660109B1 (ko) * 2014-06-25 2016-09-27 한양대학교 산학협력단 암 진단 및 치료를 위한 나노파티클
EP3218892B1 (fr) 2014-11-13 2019-10-23 Applied Medical Resources Corporation Modèles de tissu simulés et procédés
CA2970367A1 (fr) 2015-02-19 2016-08-25 Applied Medical Resources Corporation Structures de tissu simule et procedes
AU2016260331A1 (en) 2015-05-14 2017-08-17 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
CA2987520A1 (fr) * 2015-05-29 2016-12-08 Eve Pharma Ltd. Compositions vaginales ph-dependantes et methodes destinees a traiter les affections vaginales
WO2016201085A1 (fr) 2015-06-09 2016-12-15 Applied Medical Resources Corporation Modèle d'hystérectomie
ES2824529T3 (es) 2015-07-16 2021-05-12 Applied Med Resources Tejido disecable simulado
WO2017015438A1 (fr) 2015-07-22 2017-01-26 Applied Medical Resources Corporation Modèle d'appendicectomie
WO2017062757A1 (fr) 2015-10-08 2017-04-13 Massachusetts Institute Of Technology Croissance in situ de dispositifs issus de l'ingénierie tissulaire pour la régénération
KR102757131B1 (ko) 2015-11-20 2025-01-20 어플라이드 메디컬 리소시스 코포레이션 시뮬레이션된 절개가능 조직
US9861410B2 (en) 2016-05-06 2018-01-09 Medos International Sarl Methods, devices, and systems for blood flow
JP7063892B2 (ja) 2016-06-27 2022-05-09 アプライド メディカル リソーシーズ コーポレイション 模擬腹壁
CN110023340A (zh) * 2016-08-03 2019-07-16 高德美研究及发展公司 使糖胺聚糖交联的方法
AU2017307330A1 (en) * 2016-08-03 2019-03-14 Centre National De La Recherche Scientifique Double crosslinked glycosaminoglycans
HUE050368T2 (hu) * 2016-08-03 2020-11-30 Galderma Res & Dev Eljárás glükózaminoglikánok elõállítására
EP3329840B1 (fr) * 2016-12-05 2022-10-19 BIOTRONIK SE & Co. KG Système de capteur de détection de présence ou de concentration d'analytes
US11030922B2 (en) 2017-02-14 2021-06-08 Applied Medical Resources Corporation Laparoscopic training system
US10847057B2 (en) 2017-02-23 2020-11-24 Applied Medical Resources Corporation Synthetic tissue structures for electrosurgical training and simulation
KR20240150530A (ko) 2017-03-22 2024-10-15 아센디스 파마 에이에스 히드로겔 가교된 히알루론산 전구약물 조성물 및 방법
KR102118200B1 (ko) * 2017-05-18 2020-06-03 한양대학교 산학협력단 물리적 가교제를 함유하는 자가복원 고분자 네트워크, 이를 위한 조성물, 및 이를 포함하는 광학소자
US10567084B2 (en) 2017-12-18 2020-02-18 Honeywell International Inc. Thermal interface structure for optical transceiver modules
DE102018129478B4 (de) * 2018-11-22 2021-05-27 Carl Zeiss Meditec Ag Ophthalmologisches Implantat mit einem Wirkstoffabgabesystem und Verfahren zum Herstellen eines solchen ophthalmologischen Implantats
CN110204794B (zh) * 2019-06-21 2021-05-07 赣州臻丰科技有限公司 一种低成本高回弹性生物降解减震包装材料及制备方法
CN110746616A (zh) * 2019-10-25 2020-02-04 南京大学 一种含苯硼酸的纤维素水凝胶及其制备方法和应用
CN110917391A (zh) * 2019-12-26 2020-03-27 广东泰宝医疗科技股份有限公司 一种多肽修饰海藻酸钠/pva水凝胶敷料及其制备方法
CN111393834B (zh) * 2020-04-21 2021-10-15 东莞市雄林新材料科技股份有限公司 一种tpu基生物医用3d打印材料及其制备方法
CN112023109B (zh) * 2020-08-12 2021-09-28 山东百多安医疗器械股份有限公司 一种可粘附自修复止血膜及其制备方法
WO2023028572A1 (fr) * 2021-08-26 2023-03-02 Senseonics, Incorporated Médiation de dégradation de signal d'analyte in vivo
CN115245601B (zh) * 2022-01-18 2023-08-22 郑州大学第一附属医院 鼓膜修复材料及其制备方法
TWI823383B (zh) * 2022-05-09 2023-11-21 國立臺北科技大學 降低蛋白質吸附的多醣類組合物及方法
CN115337448B (zh) * 2022-08-23 2023-06-13 浙江大学 具有抗炎、抗菌及ros响应性能的单宁酸偶联的聚磷腈基水凝胶伤口敷料及其制备方法
CN115970040B (zh) * 2022-12-16 2024-07-26 北京科技大学 可黏结湿表面且易更换促修复的水凝胶敷贴及其制备方法
CN116650705B (zh) * 2023-04-10 2025-03-14 青岛大学 一种自凝胶化粉末及其应用
CN117815438B (zh) * 2023-12-27 2024-07-12 中南大学湘雅医院 一种多功能水凝胶及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594111A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexes for bioconjugate preparation

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) * 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
DE68927904T2 (de) * 1988-09-01 1997-09-04 Takeda Chemical Industries Ltd Fumagillol-Derivate
US5290807A (en) * 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
US6017954A (en) * 1989-08-10 2000-01-25 Children's Medical Center Corp. Method of treating tumors using O-substituted fumagillol derivatives
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
JPH06157344A (ja) * 1992-02-07 1994-06-03 Childrens Medical Center Corp:The 血管新生阻害のための医薬製剤及び血管新生阻害方法
US5800373A (en) * 1995-03-23 1998-09-01 Focal, Inc. Initiator priming for improved adherence of gels to substrates
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5650173A (en) * 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
CN1309833C (zh) * 1994-04-26 2007-04-11 儿童医学中心公司 血管生成抑制素及其在制备药物中的用途
US5639725A (en) * 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
US5837682A (en) * 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US6551610B2 (en) * 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
US5861372A (en) * 1996-02-22 1999-01-19 The Children's Medical Center Corporation Aggregate angiostatin and method of use
JP3964478B2 (ja) * 1995-06-30 2007-08-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
JPH11510837A (ja) * 1995-07-28 1999-09-21 フォーカル，インコーポレイテッド 薬物送達のための制御された放出薬剤および組織処置薬剤としての使用のためのマルチブロック生分解性ヒドロゲル
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
US5854221A (en) * 1996-12-12 1998-12-29 The Children's Medical Center Corporation Endothelial cell proliferation inhibitor and method of use
DK1704878T3 (da) * 1995-12-18 2013-07-01 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til deres anvendelse
US5902599A (en) * 1996-02-20 1999-05-11 Massachusetts Institute Of Technology Biodegradable polymer networks for use in orthopedic and dental applications
US5681904A (en) * 1996-04-01 1997-10-28 Minnesota Mining And Manufacturing Company Azido polymers having improved burn rate
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
EP0907666A1 (fr) * 1996-06-27 1999-04-14 G.D. Searle & Co. Particules comprenant des copolymeres amphiphiles, possedant un domaine de reticulation croisee et un domaine de noyau interne, utilisables en pharmacologie et autres applications
US6156884A (en) * 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
DK0920413T3 (da) * 1996-08-05 2003-03-03 Prolinx Inc Kompleksdannende reagens til boronforbindelser og tilsvarende komplekser
US6630577B2 (en) * 1996-08-05 2003-10-07 Prolinx, Inc. 1,2-Phenylenediboronic acid reagents and complexes
US6174861B1 (en) * 1996-10-22 2001-01-16 The Children's Medical Center Corporation Methods of inhibiting angiogenesis via increasing in vivo concentrations of endostatin protein
US6737236B1 (en) * 1997-01-08 2004-05-18 Proligo, Llc Bioconjugation of macromolecules
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
CN1271277A (zh) * 1997-07-18 2000-10-25 因菲米德有限公司 用于生物活性物质控释的生物可降解的大分子的单体
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US6391937B1 (en) * 1998-11-25 2002-05-21 Motorola, Inc. Polyacrylamide hydrogels and hydrogel arrays made from polyacrylamide reactive prepolymers
US20010049438A1 (en) * 1999-03-19 2001-12-06 Dix Connie Kim Purification of primer extension products
US6103255A (en) * 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering
US6514535B2 (en) * 1999-05-21 2003-02-04 Noveon Ip Holdings Corp. Bioadhesive hydrogels with functionalized degradable crosslinks
US6664399B1 (en) * 1999-09-02 2003-12-16 E. I. Du Pont De Nemours & Company Triazole linked carbohydrates
US6521223B1 (en) * 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6726810B2 (en) * 2000-02-25 2004-04-27 Meadwestvaco Corporation Apparatus for smoothening a paper web before coating
CA2416126C (fr) * 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Composites bioabsorbables d'acide hyaluronique derive
WO2002078947A1 (fr) * 2001-04-02 2002-10-10 Prolinx Incorporated Surfaces de detecteur permettant de detecter des substances a analyser
US6524624B1 (en) * 2001-05-16 2003-02-25 Alcide Corporation Two-part disinfecting systems and compositions and methods related thereto
US7432668B2 (en) * 2002-12-20 2008-10-07 Koninklijke Philips Electronics N.V. Sensing light emitted from multiple light sources
US6872266B1 (en) * 2003-05-30 2005-03-29 The United States Of America As Represented By The Secretary Of The Navy Triazole crosslinked polymers in recyclable energetic compositions and method of preparing the same
US20050164402A1 (en) * 2003-07-14 2005-07-28 Belisle Christopher M. Sample presentation device
US7598313B2 (en) * 2003-09-05 2009-10-06 University Of Massachusetts Amphiphilic polymer capsules and related methods of interfacial assembly
US7405183B2 (en) * 2004-07-02 2008-07-29 Halliburton Energy Services, Inc. Methods and compositions for crosslinking polymers with boronic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594111A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexes for bioconjugate preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOFFATT S.: "PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 317, May 2006 (2006-05-01), pages 10 - 13, XP005501952 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410190B2 (en) * 2009-09-22 2013-04-02 Coopervision International Holding Company, Lp Wettable hydrogel materials for use in ophthalmic applications and methods

Also Published As

Publication number Publication date
AU2007240613A1 (en) 2007-11-01
CA2649915A1 (fr) 2007-11-01
WO2007124132A2 (fr) 2007-11-01
US20100285094A1 (en) 2010-11-11
AU2007240613B2 (en) 2013-11-28
EP2012803A4 (fr) 2012-08-01
EP2012803A2 (fr) 2009-01-14

Similar Documents

Publication Publication Date Title
WO2007124132A3 (fr) Compositions polymères et procédés de production et d'utilisation de ces compositions
WO2007035296A3 (fr) Compositions polymeres et procedes de fabrication et d'utilisation correspondants
WO2006092271A3 (fr) Structures polymeres absorbant l'eau a base de matieres premieres renouvelables et procede de fabrication
MX2007009550A (es) Proceso para la produccion de polimero reticulado que contiene reticulador silano bajo productor de voc y polimero reticulado resultante.
WO2007120707A3 (fr) Composition de polyamide comprenant un agent modificateur
WO2007143159A3 (fr) Dispositifs médicaux ayant des performances améliorées
WO2008030457A3 (fr) Nanofibres, nanofilms et procédés de fabrication/utilisation correspondants
WO2004102615A3 (fr) Polymeres electroactifs
WO2007053794A3 (fr) Composés phénoliques fonctionnalisés et dispositifs absorbables fabriqués à partir desdits composés
WO2008019217A3 (fr) Polymères romp stéréoréguliers
WO2008057697A3 (fr) Particules polymères réticulées
WO2008156788A3 (fr) Polymères fonctionnalisés par des halosilanes contenant un groupe amino
WO2006122317A3 (fr) Procedes et dispositifs de nanofabrication pour l'assemblage controle de nanostructures fonctionnalisees
WO2005087821A3 (fr) Modificateurs de viscosite de dispersants fondes sur des polymeres contenant un diene
WO2007079103A3 (fr) Compositions comprenant de nouveaux composes et dispositifs electroniques produits au moyen de ces compositions
WO2007081991A3 (fr) Nouveaux materiaux conjugues dotes d’unites proquinoidales
WO2007012979A3 (fr) Compositions de polylactide and leurs utilisations
WO2007075576A3 (fr) Pate comprenant du polypyridobisimidazole et d'autres polymeres, et ses methodes de fabrication
WO2008019383A3 (fr) Matériau adhésif ou d'étanchéité à durcissement latent activé par l'humidité
WO2006128795A3 (fr) Utilisation de copolymeres sequences amphiphiles pour produire des melanges polymeres
WO2005072371A3 (fr) Sucres polymeres ramifies et leurs nucleotides
WO2006128796A3 (fr) Compositions polymeres contenant des polyolefines et des copolymeres sequences amphiphiles ainsi qu'eventuellement d'autres polymeres et/ou des charges et procedes pour colorer de telles compositions ou realiser une impression sur ces dernieres
WO2005087724A3 (fr) Nouvelles hydroxy-6-phenylphenanthridines a substitution amido
WO2009151520A3 (fr) Polymères élastomères biocompatibles et biodégradables
WO2010123300A3 (fr) Boue pour polissage mécano-chimique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07755883

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2649915

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007240613

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007755883

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007240613

Country of ref document: AU

Date of ref document: 20070420

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12226547

Country of ref document: US